Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of Origo Biopharma.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Origo Biopharma
Spain_new Flag
Country
Country
Spain
Address
Address
Parque Empresarial de Touro, Parcelas 26-27, Fonte Díaz 15822- Touro (A Coruña) España
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The combined organization will focus on translating growth factor signaling pathways into innovative therapies including lead program, ORG-129, a gastrointestinal tract restricted ALK-5 inhibitor currently in a Phase 1 clinical trial.


Lead Product(s): ORG-129

Therapeutic Area: Gastroenterology Product Name: ORG-129

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: AgomAb Therapeutics N.V

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition October 28, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY